This year, there were many takeaways from the American Society of Clinical Oncology Annual Meeting that oncology nurses can incorporate into their practice.
Each year at the American Society of Clinical Oncology Annual (ASCO) Congress, researchers from around the globe present on the latest updates in cancer care. Here’s a list of some of the key takeaways for oncology nurses.This year, there were many takeaways from the American Society of Clinical Oncology Annual Meeting that oncology nurses can incorporate into their practice
For comprehensive and ongoing coverage of the ASCO Annual Meeting, visit https://www.oncnursingnews.com/conference/asco.
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer
January 26th 2025While ctDNA positivity was linked to worse overall disease-free survival (DFS) in stage III resected colon cancer, it was associated with significantly improved DFS with celecoxib compared to placebo.